Metabolic Syndrome

From Mechanisms to Interventions
Herausgeber: Mukhopadhyay, Satinath; Mondal, Sunetra

• Broschiertes Buch

Produktbeschreibung

Metabolic Syndrome: From Mechanisms to Interventions covers all aspects of this complex and multifactorial disease, providing a cutting-edge understanding of the problem of MetS, with a particular focus on its prevention and clinical management. The book discusses practical implementable approaches to its reversal in clinical practice, encompassing the entire spectrum of MetS, from molecular understanding to clinical therapeutics and prevention. This book is a valuable resource for clinicians in multiple specialties, including endocrinologists, diabetologists, hepatologists, gynecologists and researchers in related fields who need a deep understanding of the full range of scientific and clinical aspects of metabolic syndrome.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science & Technology
• Seitenzahl: 700
• Erscheinungstermin: 10. November 2023
• Englisch
• Abmessung: 214mm x 277mm x 35mm
• Gewicht: 1832g
• ISBN-13: 9780323857321
• ISBN-10: 0323857329
• Artikelnr.: 63120942

Inhaltsangabe

Section 1: Introduction to Metabolic Syndrome
1. Beyond the Metabolic Syndrome: Adverse Lifelong Influences
Emanating From Insulin Resistance On The Aging Process In Non-Diabetics
2. Metabolic syndrome- is it a disease or a risk factor for other
disorders?
3. Intrauterine malnutrition and future risk of Metabolic Syndrome
4. Intervening at the stage of metabolic syndrome to prevent type 2
diabetes- is it justified?
5. Dietary fats and Metabolic Syndrome: How strong is the association?
6. Metabolic Syndrome needs treatment but with lifestyle interventions
alone
Section 2: Epidemiology of Metabolic Syndrome
7. Epidemiology of Metabolic Syndrome: Global Scenario
8. Epidemiology of Metabolic Syndrome in South and South East Asians
9. Barker's Hypothesis and Metabolic Syndrome
10. Metabolic syndrome in Australian aborigines
Section 3: Pathogenesis and pathophysiology of Metabolic Syndrome
11. Diet in the pathogenesis of metabolic syndrome: Role of Sugar, salt and
fat
12. Vitamin D deficiency and metabolic syndrome - Is there a causality?
13. Role of inflammation in the pathogenesis of Metabolic Syndrome
14. Role of oxidative stress in the pathogenesis of Metabolic Syndrome
15. Mitochondrial dysfunction and Metabolic syndrome
16. The entero-insular axis and metabolic syndrome
17. Type I interferons in metabolic syndrome
18. Immunometabolism, an emerging subspecialty of Metabolic Syndrome
19. Pathophysiology of metabolic syndrome: current concepts
20. Role of Circadian rhythms in Metabolic Syndrome
21. Ectopic fat distribution and its role in Metabolic Syndrome
22. The role of genetic and epigenetic factors in familial clustering of
metabolic syndrome
23. High carbohydrate diet in the pathogenesis of Metabolic Syndrome
24. Endocrine disruptors in the pathogenesis of metabolic syndrome
25. Autoimmunity and Metabolic Syndrome
Section 4: Metabolic Syndrome - multisystemic manifestation
26. The burden of atherosclerotic cardiovascular disease in metabolic
syndrome
27. Mechanisms of atherosclerosis in metabolic syndrome
28. NAFLD, the hepatic manifestation of metabolic syndrome
29. Obesity associated hypogonadism - a growing concern in metabolic
syndrome
30. Sleep apnea - A cause or a consequence of Metabolic Syndrome?
31. The metabolic syndrome in psychiatry
32. Renal manifestations of Metabolic Syndrome: The link between obesity
and chronic kidney disease
33. Unraveling neuropathic manifestations of metabolic syndrome: role of
corneal confocal microscopy
34. Metabolic Syndrome and Periodontitis: pathophysiologic links and
clinical implications
35. Metabolic Syndrome and Bone Health
36. Insulin resistance and the risk of Osteoporosis
37. Glucagon and Metabolic Syndrome
Section 5: Clinical assessment of Metabolic Syndrome
38. Measures of adiposity- from BMI to Waist circumference to neck
circumference to body fat
39. The Role of Prediabetes in the Metabolic Syndrome
40. Assessment of insulin resistance: from the bench to bedside
Section 6: Management of Metabolic Syndrome
41. Dietary interventions to combat obesity and Metabolic Syndrome
42. Role of precision diet and intermittent fasting in the management of
metabolic syndrome
43. Nutritional and Cognitive interventions to reduce cardiovascular risk
in Metabolc Syndrome
44. Role of exercise in the prevention and management of Metabolic Syndrome
45. Should Vitamin D be used to treat Metabolic Syndrome?
46. Pharmacologic therapies in Metabolic syndrome with special reference to
NAFLD
47. Role of newer anti-diabetes drugs in prediabetes: A systematic review
48. Management of Insulin resistance in PCOS
49. The role of bariatric surgery in the management of metabolic syndrome
50. Anti-inflammatory interventions to mitigate cardiovascular risk in
metabolic syndrome
51. Management of new onset dysglycemia in transplant recipients
52. Prevention of Type 2 diabetes in Metabolic Syndrome: Role of the
geneticist
53. Managing Metabolic Syndrome in a general practice setting
54. Dietary interventions to reduce cardiovascular risk in Metabolic
Syndrome
55. Management of Lipid Abnormalities in Metabolic Syndrome
Section 7: Metabolic Syndrome in children and adolescents
56. Overview of metabolic syndrome in children and adolescents
57. Overview of metabolic syndrome in children and adolescents: Indian
perspective
58. Metabolic syndrome in children and adolescents: Does ethnicity matter?
59. NAFLD in children and adolescents
60. PCOS in adolescents: Role of insulin resistance
61. The inter relationship between polycystic ovary syndrome (PCOS) and
metabolic syndrome
62. Dietary interventions to improve cardiometabolic health outcomes in
children and adolescents
Section 8: Metabolic Syndrome: Controversies to consensus
63. Metabolic Syndrome -are our definitiond fit for purpose?
64. Metabolic Syndrome: treat the whole or address each part?
65. Metabolic Syndrome and cancer risk
Section 9: Areas for future research
66. Assessment of abdominal obesity: to measure visceral fat, subcutaneous
fat or both?
67. Obesity-mediated insulin resistance in target tissues: Role of
adipokines, hepatokines and myokines
68. Can bariatric surgery cure metabolic syndrome?
69. Gut microbiota and metabolic syndrome: what's new?
70. COVID19 and metabolic syndrome - an unholy alliance
71. MicroRNA modulation in metabolic syndrome: a novel insight in
cardiometabolic disease
72. Role of artificial intelligence in tackling the metabolic syndrome
pandemic
73. Glucose handling by the brain and its impact on metabolic syndrome
74. Impact of Hypoglycemia on cardiovascular risk in metabolic syndrome
75. Dietary interventions to combat obesity in metabolic syndrome- role of
time restricted eating